Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INERTIA: Ferric carboxymaltose in TAVI/SAVR
NCT04786769Phase 4Unknown
- Sponsor
- Hospital de Santa Cruz
- Start
- Jan 2022
- Primary completion
- Jan 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Hospital de Santa Cruz. Status: unknown.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04786769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04786769.